Acetate was demonstrated to be protective against BPD in the mouse model; the mice treated with acetate had a lower level of IL-1β, IL-18, TNF-α, caspase-1, and NLRP3, respectively, while having a higher level of GPR43 (Zhang et al., 2021). This evidence concerns the gene IL1B and bronchopulmonary dysplasia.